Zoledronic acid is effective in the prevention of bone loss in premenopausal women with breast cancer being treated with endocrine therapy. The benefit of zoledronic acid probably extends for some years after cessation of therapy.
Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancer / Bertoldo, F; Tonini, G; Vincenzi, B; Santini, D. - In: NATURE REVIEWS. CLINICAL ONCOLOGY. - ISSN 1759-4774. - 6:4(2009), pp. 191-192. [10.1038/nrclinonc.2009.24]
Medical oncology: zoledronic acid prevents bone loss in early-stage breast cancer
Santini D
2009
Abstract
Zoledronic acid is effective in the prevention of bone loss in premenopausal women with breast cancer being treated with endocrine therapy. The benefit of zoledronic acid probably extends for some years after cessation of therapy.File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
